Skip to main content
Interparfums logo

Interparfums — Investor Relations & Filings

Ticker · ITP ISIN · FR0004024222 LEI · 969500SARWF33OPQED48 PA Manufacturing
Filings indexed 678 across all filing types
Latest filing 2011-12-20 M&A Activity
Country FR France
Listing PA ITP

Interparfums specializes in the creation, manufacturing, and distribution of prestige fragrances and related cosmetic products. Operating primarily as an exclusive worldwide licensee, the company develops and markets perfumes for a portfolio of renowned luxury and fashion brands. It manages the entire product lifecycle, from concept and scent development to packaging, marketing, and global distribution. In addition to its core licensing business, the company also develops its own proprietary fragrance brands.

Recent filings

Filing Released Lang Actions
Interparfums SA and Burberry Group in discussions about potential new operating structure for fragrance and beauty business and status of current license
M&A Activity Classification · 99% confidence The document text discusses ongoing discussions between Interparfums SA and Burberry Group regarding a potential new operating structure for the Burberry fragrance and beauty business, including Burberry's right to evaluate buying out the existing license. This content relates to a significant corporate transaction or strategic change involving potential mergers, acquisitions, or major contractual shifts. This aligns best with the 'M&A Activity' category (TAR), which covers merger proposals or takeover bids, as the discussion centers on restructuring a major licensing agreement which could lead to a buyout or change in control/operation. It is not a standard financial report (10-K, IR, ER) or a routine announcement (DIV, DIRS). Given the subject matter of restructuring a major business relationship, TAR is the most appropriate fit.
2011-12-20 English
Repetto et Interparfums S.A. signent un accord de licence parfums exclusif
M&A Activity Classification · 99% confidence The document announces a strategic business agreement: Repetto and Interparfums signed an exclusive 13-year license agreement for the creation and development of perfume lines under the Repetto brand, effective January 1, 2012, with a launch expected in 2013. This is a significant corporate event related to business strategy, licensing, and future product lines, but it does not fit neatly into standard financial reports (10-K, IR, ER) or specific corporate actions like dividends, director dealings, or capital changes. It is a material announcement concerning the company's operations and future revenue streams. Given the options, this type of strategic partnership announcement, which is material but not a standard regulatory filing form, is best categorized as a general Regulatory Filing (RNS) or potentially a general announcement, as it doesn't match M&A (TAR) or Financing (CAP). Since it is a specific, material business development announcement, RNS (Regulatory Filings/Miscellaneous Announcement) is the most appropriate fallback category.
2011-12-07 French
Repetto and Interparfums S.A. sign an exclusive fragrance license agreement
Regulatory Filings Classification · 90% confidence The document announces a significant business event: the signing of a 13-year worldwide license agreement between Repetto and Interparfums for fragrance creation and distribution. This is a strategic corporate action related to business development and future product lines, not a standard periodic financial report (like 10-K, IR, ER) or a shareholder vote result. It fits best under the category of major corporate transactions or strategic updates. Since there is no specific code for 'License Agreement' or 'Strategic Partnership', I must evaluate the provided options. It is not a Director's Dealing (DIRS), Capital Change (CAP/SHA), Delisting (DLST), or Dividend (DIV). It is a material announcement that impacts the company's future operations and potential revenue streams. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a significant, non-standard corporate announcement that doesn't fit the other specific categories, although 'TAR' (M&A Activity) is sometimes used broadly for major deals, this is a licensing deal, not a merger or takeover. However, RNS is the general catch-all for regulatory announcements not covered elsewhere. Since this is a press release announcing a major agreement, RNS is the most suitable general classification.
2011-12-07 English
Déclaration mensuelle du nombre total de droits de vote et du nombre d’actions composant le capital
Share Issue/Capital Change Classification · 95% confidence The document is titled "Déclaration mensuelle du nombre total de droits de vote et du nombre d'actions composant le capital" (Monthly declaration of the total number of voting rights and the number of shares comprising the capital) and is dated 'Au 30 Novembre 2011'. It explicitly references French commercial code (Code de Commerce) and AMF regulations (Autorité des Marchés Financiers). This type of mandatory periodic disclosure regarding the total share capital and voting rights structure is a specific regulatory filing. It does not fit the definitions for Annual Report (10-K), Earnings Release (ER), Interim Report (IR), or a simple Dividend Notice (DIV). Since it is a specific regulatory disclosure about capital structure and voting rights, it is best classified under the general 'Regulatory Filings' (RNS) as a fallback, although it is highly specific. However, looking closely at the definitions, none perfectly match a 'Monthly Voting Rights Declaration'. Given the options, RNS is the most appropriate general regulatory filing category for mandatory disclosures not covered elsewhere. The document length is very short (945 chars), suggesting it is a direct filing rather than an announcement of a larger report.
2011-12-02 French
Perspectives 2012 : Un chiffre d'affaires de 400 millions d'euros (+8 %)
Earnings Release Classification · 95% confidence The document provides a forward-looking business update, discussing performance drivers for 2011 and projections for 2012, including revenue estimates (e.g., 'chiffre d'affaires consolidé proche de 370 millions d'euros' for 2011 and 'devrait atteindre 400 millions d'euros' for 2012). It also lists upcoming events like the 'Publication du chiffre d'affaires 2011' on January 24, 2012. This content structure—reviewing the past period and projecting the next, often released before the full formal report—is characteristic of an Earnings Release (ER) or a preliminary management discussion. Since it focuses on key financial highlights and outlook rather than being a full, comprehensive report (like a 10-K or IR), 'ER' is the most appropriate classification. It is not a transcript (CT), a formal annual report (10-K), or just an announcement of a report (RPA), as it contains substantive financial commentary. FY 2011
2011-11-16 French
2012 outlook: Annual sales of €400 million (+8%)
Earnings Release Classification · 97% confidence The document provides a summary of sales performance for 2011 and an outlook for 2012, focusing on key brand drivers (Jimmy Choo, Montblanc, Burberry Body) and expected consolidated sales figures (€370 million for 2011, projected €400 million for 2012). It concludes with a list of upcoming events, including the 'Publication of 2011 sales' scheduled for January 24, 2012. This content structure—a brief summary of recent performance and future guidance, often released before a full quarterly or annual report—is characteristic of an Earnings Release (ER). It is not a full financial report (like 10-K or IR), nor is it a transcript (CT) or a presentation (IP). Since it announces preliminary results and outlook, ER is the most appropriate classification. FY 2011
2011-11-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.